1451 - 1500 of 5832 Results
Title
Year
- Physical inactivity links depressive symptoms and cognitive functioning among individuals with Parkinson’s disease.2022OPENTitle: Physical inactivity links depressive symptoms and cognitive functioning among individuals with Parkinson’s disease.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 36Issue #: 6Start Page: 505End Page: 512Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific, author manuscriptDOI - Digital Object Identifier: 10.1037/neu0000837Best OA location URL: https://doi.org/10.1037/neu0000837Citation Count: 5
- Association of Concurrent Olfactory Dysfunction and Probable Rapid Eye Movement Sleep Behavior Disorder with Early Parkinson's Disease Progression2022OPENTitle: Association of Concurrent Olfactory Dysfunction and Probable Rapid Eye Movement Sleep Behavior Disorder with Early Parkinson's Disease ProgressionJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 7Start Page: 909End Page: 919Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13511Best OA location URL: https://doi.org/10.1002/mdc3.13511Citation Count: 4
- Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohorts2022OPENTitle: Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohortsJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 93Issue #: 9Start Page: 952End Page: 959Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1136/jnnp-2021-327376Best OA location URL: https://jnnp.bmj.com/content/jnnp/93/9/952.full.pdfCitation Count: 9
- Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease2022OPENTitle: Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-022-01388-7Best OA location URL: https://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-022-01388-7Citation Count: 54
- Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms2022OPENTitle: Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive SymptomsJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1644End Page: 1653Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29128Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545646Citation Count: 64
-
OPENTitle: Genome Sequencing in the Parkinson Disease ClinicJournal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 8Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxg.0000000000200002Best OA location URL: https://ng.neurology.org/content/nng/8/4/e200002.full.pdfCitation Count: 11
-
OPENTitle: Measuring evolution learning: impacts of student participation incentives and test timingJournal Name: Evolution: Education and OutreachPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s12052-022-00166-2Best OA location URL: https://evolution-outreach.biomedcentral.com/counter/pdf/10.1186/s12052-022-00166-2Citation Count: 2
-
OPENTitle: Multimodal deep learning for Alzheimer’s disease dementia assessmentJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-022-31037-5Best OA location URL: https://www.nature.com/articles/s41467-022-31037-5.pdfCitation Count: 119
- Satellite repeat transcripts modulate heterochromatin condensates and safeguard chromosome stability in mouse embryonic stem cells2022OPENTitle: Satellite repeat transcripts modulate heterochromatin condensates and safeguard chromosome stability in mouse embryonic stem cellsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-022-31198-3Best OA location URL: https://www.nature.com/articles/s41467-022-31198-3.pdfCitation Count: 34
- Description of a European memory clinic cohort undergoing amyloid‐PET: The AMYPAD Diagnostic and Patient Management Study2022OPENTitle: Description of a European memory clinic cohort undergoing amyloid‐PET: The AMYPAD Diagnostic and Patient Management StudyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 3Start Page: 844End Page: 856Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12696Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12696Citation Count: 11
- Differential impact of individual autonomic domains on clinical outcomes in Parkinson’s disease2022OPENTitle: Differential impact of individual autonomic domains on clinical outcomes in Parkinson’s diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 269Issue #: 10Start Page: 5510End Page: 5520Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-022-11221-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-022-11221-9.pdfCitation Count: 15
-
OPENTitle: Functional Analyses of Two Novel LRRK2 Pathogenic Variants in Familial Parkinson′s DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1761End Page: 1767Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29124Best OA location URL: https://biblio.ugent.be/publication/8763209/file/8763211.pdfCitation Count: 5
- Opicapone as an Add-on to Levodopa in Patients with Parkinson’s Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON Trial2022OPENTitle: Opicapone as an Add-on to Levodopa in Patients with Parkinson’s Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON TrialJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 3Start Page: 1409End Page: 1425Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-022-00371-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-022-00371-7.pdfCitation Count: 6
- The Association of CSF sTREM2 With Cognitive Decline and Its Dynamic Change in Parkinson's Disease: Analysis of the PPMI Cohort2022OPENTitle: The Association of CSF sTREM2 With Cognitive Decline and Its Dynamic Change in Parkinson's Disease: Analysis of the PPMI CohortJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.892493Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.892493/pdfCitation Count: 16
-
OPENTitle: Racial disparities in hypertension management among multiple sclerosis patientsJournal Name: Multiple Sclerosis and Related DisordersPublisher: Elsevier BVVol: 64Issue #:Start Page: 103972End Page: 103972Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.msard.2022.103972Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308758Citation Count: 10
- Relationships of self-reported and objective measures of sleep, sleepiness, and sleep quality in Parkinson's disease2022OPENTitle: Relationships of self-reported and objective measures of sleep, sleepiness, and sleep quality in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 57End Page: 61Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.009Best OA location URL: http://manuscript.elsevier.com/S1353802022001924/pdf/S1353802022001924.pdfCitation Count: 5
- Cortical and Subthalamic Nucleus Spectral Changes During Limb Movements in Parkinson's Disease Patients with and Without Dystonia2022OPENTitle: Cortical and Subthalamic Nucleus Spectral Changes During Limb Movements in Parkinson's Disease Patients with and Without DystoniaJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1683End Page: 1692Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29057Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29057Citation Count: 7
- Integrating Data Directly into Publications with Augmented Reality and Web-Based Technologies – Schol-AR2022OPENTitle: Integrating Data Directly into Publications with Augmented Reality and Web-Based Technologies – Schol-ARJournal Name: Scientific DataPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41597-022-01426-yBest OA location URL: https://www.nature.com/articles/s41597-022-01426-y.pdfCitation Count: 6
- Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairment2022OPENTitle: Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairmentJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 4Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcac155Best OA location URL: https://academic.oup.com/braincomms/article-pdf/4/4/fcac155/45028282/fcac155.pdfCitation Count: 20
- Association Between Dopaminergic Medications and the Evolution of REM Sleep Behavior Disorder in Parkinson's Disease2022OPENTitle: Association Between Dopaminergic Medications and the Evolution of REM Sleep Behavior Disorder in Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.880583Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.880583/pdfCitation Count: 3
- Associations of Sleep Disorders With Depressive Symptoms in Early and Prodromal Parkinson’s Disease2022OPENTitle: Associations of Sleep Disorders With Depressive Symptoms in Early and Prodromal Parkinson’s DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.898149Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.898149/pdfCitation Count: 4
- Breakthrough News in Adenoviral Vector‐Mediated AADC Gene Therapy: Lessons from the Success in AADC Deficiency and Possible Future Applications2022OPENTitle: Breakthrough News in Adenoviral Vector‐Mediated AADC Gene Therapy: Lessons from the Success in AADC Deficiency and Possible Future ApplicationsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 6Start Page: 737End Page: 738Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13503Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13503Citation Count: 1
- Lipase regulation of cellular fatty acid homeostasis as a Parkinson’s disease therapeutic strategy2022OPENTitle: Lipase regulation of cellular fatty acid homeostasis as a Parkinson’s disease therapeutic strategyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00335-6Best OA location URL: https://www.nature.com/articles/s41531-022-00335-6.pdfCitation Count: 12
- WHOPPA Enables Parallel Assessment of Leucine-Rich Repeat Kinase 2 and Glucocerebrosidase Enzymatic Activity in Parkinson’s Disease Monocytes2022OPENTitle: WHOPPA Enables Parallel Assessment of Leucine-Rich Repeat Kinase 2 and Glucocerebrosidase Enzymatic Activity in Parkinson’s Disease MonocytesJournal Name: Frontiers in Cellular NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncel.2022.892899Best OA location URL: https://www.frontiersin.org/articles/10.3389/fncel.2022.892899/pdfCitation Count: 15
- Distinct profiles of LRRK2 activation and Rab GTPase phosphorylation in clinical samples from different PD cohorts2022OPENTitle: Distinct profiles of LRRK2 activation and Rab GTPase phosphorylation in clinical samples from different PD cohortsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00336-5Best OA location URL: https://www.nature.com/articles/s41531-022-00336-5.pdfCitation Count: 18
-
OPENTitle: Structure of the second phosphoubiquitin–binding site in parkinJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 298Issue #: 7Start Page: 102114End Page: 102114Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.jbc.2022.102114Best OA location URL: http://www.jbc.org/article/S0021925822005555/pdfCitation Count: 19
- Evaluating the Use of Digital Biomarkers to Test Treatment Effects on Cognition and Movement in Patients with Lewy Body Dementia2022OPENTitle: Evaluating the Use of Digital Biomarkers to Test Treatment Effects on Cognition and Movement in Patients with Lewy Body DementiaJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 6Start Page: 1991End Page: 2004Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-213126Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd213126?id=journal-of-parkinsons-disease%2Fjpd213126Citation Count: 8
- Longitudinal Cohort Study of Verbatim-Reported Postural Instability Symptoms as Outcomes for Online Parkinson’s Disease Trials2022OPENTitle: Longitudinal Cohort Study of Verbatim-Reported Postural Instability Symptoms as Outcomes for Online Parkinson’s Disease TrialsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 6Start Page: 1969End Page: 1978Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-223274Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223274?id=journal-of-parkinsons-disease%2Fjpd223274Citation Count: 9
-
OPENTitle: Predicting the onset of freezing of gait in Parkinson’s diseaseJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 22Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-022-02713-2Best OA location URL: https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-022-02713-2Citation Count: 13
- PRKRAP1 and Other Pseudogenes in Movement Disorders: The Troublemakers in Genetic Analyses Are More Than Genomic Fossils2022OPENTitle: PRKRAP1 and Other Pseudogenes in Movement Disorders: The Troublemakers in Genetic Analyses Are More Than Genomic FossilsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 5Start Page: 698End Page: 702Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13499Best OA location URL: https://doi.org/10.1002/mdc3.13499Citation Count: 0
- Quantitative Digitography Measures Motor Symptoms and Disease Progression in Parkinson’s Disease2022OPENTitle: Quantitative Digitography Measures Motor Symptoms and Disease Progression in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 6Start Page: 1979End Page: 1990Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-223264Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223264?id=journal-of-parkinsons-disease%2Fjpd223264Citation Count: 12
- Association of Structural Measurements of Brain Reserve With Motor Progression in Patients With Parkinson Disease2022OPENTitle: Association of Structural Measurements of Brain Reserve With Motor Progression in Patients With Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000200814Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613818Citation Count: 13
-
OPENTitle: Disease Progression in Multiple System Atrophy—Novel Modeling Framework and Predictive FactorsJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1719End Page: 1727Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29077Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29077Citation Count: 8
-
OPENTitle: Long‐term independence and quality of life after subthalamic stimulation in Parkinson diseaseJournal Name: European Journal of NeurologyPublisher: WileyVol: 29Issue #: 9Start Page: 2645End Page: 2653Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/ene.15436Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543065Citation Count: 4
- Technical Performance Evaluation of Olink Proximity Extension Assay for Blood-Based Biomarker Discovery in Longitudinal Studies of Alzheimer's Disease2022OPENTitle: Technical Performance Evaluation of Olink Proximity Extension Assay for Blood-Based Biomarker Discovery in Longitudinal Studies of Alzheimer's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.889647Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.889647/pdfCitation Count: 27
-
OPENTitle: Unraveling trajectories of diffusive particles on networksJournal Name: Physical Review ResearchPublisher: American Physical Society (APS)Vol: 4Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1103/physrevresearch.4.023182Best OA location URL: http://link.aps.org/pdf/10.1103/PhysRevResearch.4.023182Citation Count: 3
- Are Virtual Objective Assessments of Fall‐Risk Feasible and Safe for People with Parkinson's Disease?2022OPENTitle: Are Virtual Objective Assessments of Fall‐Risk Feasible and Safe for People with Parkinson's Disease?Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 6Start Page: 799End Page: 804Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13494Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13494Citation Count: 6
- Association of Olfactory Performance With Motor Decline and Age at Onset in People With Parkinson Disease and the LRRK2 G2019S Variant2022OPENTitle: Association of Olfactory Performance With Motor Decline and Age at Onset in People With Parkinson Disease and the LRRK2 G2019S VariantJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000200737Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484727Citation Count: 4
- ER-lysosome lipid transfer protein VPS13C/PARK23 prevents aberrant mtDNA-dependent STING signaling2022OPENTitle: ER-lysosome lipid transfer protein VPS13C/PARK23 prevents aberrant mtDNA-dependent STING signalingJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 221Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1083/jcb.202106046Best OA location URL: https://rupress.org/jcb/article-pdf/221/7/e202106046/1434249/jcb_202106046.pdfCitation Count: 50
-
OPENTitle: Targeted copy number variant identification across the neurodegenerative disease spectrumJournal Name: Molecular Genetics & Genomic MedicinePublisher: WileyVol: 10Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mgg3.1986Best OA location URL: https://ir.lib.uwo.ca/cgi/viewcontent.cgi?article=1101&context=neurosci_inst_pubsCitation Count: 4
- Quantitative detection of α-Synuclein and Tau oligomers and other aggregates by digital single particle counting2022OPENTitle: Quantitative detection of α-Synuclein and Tau oligomers and other aggregates by digital single particle countingJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00330-xBest OA location URL: https://www.nature.com/articles/s41531-022-00330-x.pdfCitation Count: 26
-
OPENTitle: A unifying model for the role of the ATG8 system in autophagyJournal Name: Journal of Cell SciencePublisher: The Company of BiologistsVol: 135Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1242/jcs.258997Best OA location URL: https://doi.org/10.1242/jcs.258997Citation Count: 16
-
OPENTitle: Cellular mechanism of action of 2-nitroimidazoles as hypoxia-selective therapeutic agentsJournal Name: Redox BiologyPublisher: Elsevier BVVol: 52Issue #:Start Page: 102300End Page: 102300Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.redox.2022.102300Best OA location URL: https://doi.org/10.1016/j.redox.2022.102300Citation Count: 8
- Coping Styles in Patients with Parkinson’s Disease: Consideration in the Co-Designing of Integrated Care Concepts2022OPENTitle: Coping Styles in Patients with Parkinson’s Disease: Consideration in the Co-Designing of Integrated Care ConceptsJournal Name: Journal of Personalized MedicinePublisher: MDPI AGVol: 12Issue #: 6Start Page: 921End Page: 921Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/jpm12060921Best OA location URL: https://www.mdpi.com/2075-4426/12/6/921/pdf?version=1654088438Citation Count: 3
- Exploration of whether socioeconomic factors affect the results of priority setting partnerships: updating the top 10 research priorities for the management of Parkinson’s in an international setting2022OPENTitle: Exploration of whether socioeconomic factors affect the results of priority setting partnerships: updating the top 10 research priorities for the management of Parkinson’s in an international settingJournal Name: BMJ OpenPublisher: BMJVol: 12Issue #: 6Start Page: e049530End Page: e049530Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1136/bmjopen-2021-049530Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/12/6/e049530.full.pdfCitation Count: 3
- Intracerebral administration of a modified antisense oligonucleotide targeting the dopamine system in a mouse model of Parkinson’s disease2022OPENTitle: Intracerebral administration of a modified antisense oligonucleotide targeting the dopamine system in a mouse model of Parkinson’s diseaseJournal Name: STAR ProtocolsPublisher: Elsevier BVVol: 3Issue #: 2Start Page: 101445End Page: 101445Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.xpro.2022.101445Best OA location URL: https://doi.org/10.1016/j.xpro.2022.101445Citation Count: 0
-
OPENTitle: Molecular mechanisms defining penetrance of LRRK2-associated Parkinson’s diseaseJournal Name: Medizinische GenetikPublisher: Walter de Gruyter GmbHVol: 34Issue #: 2Start Page: 103End Page: 116Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1515/medgen-2022-2127Best OA location URL: https://www.degruyter.com/document/doi/10.1515/medgen-2022-2127/pdfCitation Count: 1
- Pre‐existing humoral immune comebacks control the development of the severe form of coronavirus disease 2019 in Gaucher patients2022OPENTitle: Pre‐existing humoral immune comebacks control the development of the severe form of coronavirus disease 2019 in Gaucher patientsJournal Name: Clinical and Translational DiscoveryPublisher: WileyVol: 2Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/ctd2.96Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ctd2.96Citation Count: 6
-
OPENTitle: Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson’s diseaseJournal Name: Cell Reports MedicinePublisher: Elsevier BVVol: 3Issue #: 6Start Page: 100661End Page: 100661Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.xcrm.2022.100661Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245058Citation Count: 74
- The Parkinson’s disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability2022OPENTitle: The Parkinson’s disease protein alpha-synuclein is a modulator of processing bodies and mRNA stabilityJournal Name: CellPublisher: Elsevier BVVol: 185Issue #: 12Start Page: 2035End Page: 2056.e33Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cell.2022.05.008Best OA location URL: http://www.cell.com/article/S009286742200592X/pdfCitation Count: 79